TECTONIC THERAPEUTIC, INC. Depreciation and Amortization
TECTONIC THERAPEUTIC, INC. (TECX) reported Depreciation and Amortization of $589.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $285.00K, a 16.18% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $304.00K, a 15.56% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $333.00K, a 34.45% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $342.00K, a 19.34% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for fiscal 2025 was $1.38M, a 16.41% decline from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for fiscal 2024 was $1.65M, a 11.30% increase from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for fiscal 2023 was $1.48M, a 2.64% increase from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. depreciation, depletion and amortization for fiscal 2022 was $1.44M, a 2.93% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 3 month as first filed | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 6 month as first filed | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 9 month as first filed | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $589.00K 10-Q · filed 2026-08-06 | $922.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $304.00K 10-Q · filed 2026-05-07 | $637.00K derived: sum of 2 quarters · filed 2026-05-07 | $979.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.32M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $675.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.01M derived: sum of 3 quarters · filed 2026-08-06 | $1.38M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $342.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $682.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.04M 10-Q · filed 2025-11-06 | $1.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $340.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $700.00K 10-Q · filed 2026-08-06 | $1.21M derived: sum of 3 quarters · filed 2026-08-06 | $1.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $360.00K 10-Q · filed 2026-05-07 | $868.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.29M derived: sum of 3 quarters · filed 2026-05-07 | $1.63M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $932.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.27M derived: sum of 3 quarters · filed 2026-02-26 | $1.65M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $424.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $760.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.14M 10-Q · filed 2025-11-06 | $1.51M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $713.00K 10-Q · filed 2025-08-07 | $1.09M derived: sum of 3 quarters · filed 2025-08-07 | $1.46M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $377.00K 10-Q · filed 2025-05-08 | $0.00 10-Q · filed 2024-05-09 | $750.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.12M derived: sum of 3 quarters · filed 2025-05-08 | $1.41M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $744.00K derived: sum of 2 quarters · filed 2025-03-20 | $1.03M derived: sum of 3 quarters · filed 2025-03-20 | $1.48M 10-K · filed 2025-03-20 | $617.00K 10-K · filed 2024-03-14 | |||
| 2023-09-30 | $371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $660.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.10M 10-Q · filed 2024-11-12 | $617.00K 10-Q · filed 2023-11-09 | $1.32M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $289.00K 10-Q · filed 2023-08-10 | $734.00K 10-Q · filed 2024-08-14 | $617.00K 10-Q · filed 2023-08-10 | $952.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.29M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2023-03-31 | $328.00K 10-Q · filed 2024-05-09 | $663.00K derived: sum of 2 quarters · filed 2024-05-09 | $999.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.35M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $671.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.02M derived: sum of 3 quarters · filed 2024-03-14 | $1.44M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $336.00K 10-Q · filed 2022-11-08 | $690.00K derived: sum of 2 quarters · filed 2023-08-10 | $1.10M 10-Q · filed 2023-11-09 | $1.52M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-06-30 | $354.00K 10-Q · filed 2023-08-10 | $753.00K 10-Q · filed 2023-08-10 | $1.19M derived: sum of 3 quarters · filed 2023-08-10 | $1.56M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $399.00K 10-Q · filed 2023-05-11 | $835.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.21M derived: sum of 3 quarters · filed 2023-05-11 | $1.51M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $810.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.11M derived: sum of 3 quarters · filed 2023-03-23 | $1.40M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $374.00K 10-Q · filed 2022-11-08 | $673.00K derived: sum of 2 quarters · filed 2022-11-08 | $963.00K 10-Q · filed 2022-11-08 | $1.27M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $299.00K 10-Q · filed 2022-08-09 | $589.00K 10-Q · filed 2022-08-09 | $899.00K derived: sum of 3 quarters · filed 2022-08-09 | $1.20M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $291.00K 10-Q · filed 2022-05-10 | $600.00K derived: sum of 2 quarters · filed 2022-05-10 | $901.00K derived: sum of 3 quarters · filed 2022-05-10 | $1.20M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $610.00K derived: sum of 2 quarters · filed 2022-03-17 | $911.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.21M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $301.00K 10-Q · filed 2021-11-04 | $314.00K 10-Q · filed 2020-11-05 | $602.00K derived: sum of 2 quarters · filed 2021-11-04 | $898.00K 10-Q · filed 2021-11-04 | $1.13M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | $301.00K 10-Q · filed 2021-08-05 | $584.00K 10-Q · filed 2021-08-05 | $829.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.04M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $283.00K 10-Q · filed 2021-05-13 | $528.00K derived: sum of 2 quarters · filed 2021-05-13 | $743.00K derived: sum of 3 quarters · filed 2021-05-13 | $943.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $460.00K derived: sum of 2 quarters · filed 2021-03-18 | $660.00K derived: sum of 3 quarters · filed 2021-03-18 | $850.00K 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $215.00K 10-Q · filed 2020-11-05 | $415.00K derived: sum of 2 quarters · filed 2020-11-05 | $605.00K 10-Q · filed 2020-11-05 | $789.00K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $390.00K 10-Q · filed 2020-08-06 | $574.00K derived: sum of 3 quarters · filed 2020-08-06 | $704.00K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $190.00K 10-Q · filed 2020-05-07 | $374.00K derived: sum of 2 quarters · filed 2020-05-07 | $504.00K derived: sum of 3 quarters · filed 2020-05-07 | $549.00K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $314.00K derived: sum of 2 quarters · filed 2020-03-16 | $359.00K derived: sum of 3 quarters · filed 2020-03-16 | $380.00K 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $175.00K derived: sum of 2 quarters · filed 2019-11-07 | $196.00K 10-Q · filed 2019-11-07 | $213.00K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $66.00K 10-Q · filed 2019-08-08 | $83.00K derived: sum of 3 quarters · filed 2019-08-08 | $96.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $21.00K 10-Q · filed 2019-05-13 | $38.00K derived: sum of 2 quarters · filed 2019-05-13 | $51.00K derived: sum of 3 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $30.00K derived: sum of 2 quarters · filed 2019-03-25 | $45.00K 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $28.00K 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | $15.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |